1.2.40.0.34.10.55/static-2015-03-31T000000: Unterschied zwischen den Versionen

Aus HL7 Austria MediaWiki
Wechseln zu: Navigation, Suche
[unmarkierte Version][unmarkierte Version]
(Automatic ADBot page (02cb37ebdefcc98836856b9769498689609a6db8))
(Automatic ADBot page (02cb37ebdefcc98836856b9769498689609a6db8))
 
(3 dazwischenliegende Versionen desselben Benutzers werden nicht angezeigt)
Zeile 1: Zeile 1:
  
<table xmlns="http://www.w3.org/1999/xhtml" class="artdecor" width="100%" border="0" cellspacing="3" cellpadding="2" style="background: transparent;"><tr style="vertical-align: top;"><th style="width: 20em; text-align: left;">Id</th><td style="text-align: left;">1.2.40.0.34.10.55</td><th style="width: 20em; text-align: left;">Gültigkeit</th><td style="text-align: left;">2015‑03‑31</td></tr><tr style="vertical-align: top;"><th style="width: 20em; text-align: left;">Status</th><td style="text-align: left;">[[File:Kgreen.png|14px]] Definitiv</td><th style="width: 20em; text-align: left;">Versions-Label</th><td style="text-align: left;"></td></tr><tr style="vertical-align: top;"><th style="width: 20em; text-align: left;">Name</th><td style="text-align: left;">ELGA_MammogramAssessment</td><th style="width: 20em; text-align: left;">Anzeigename</th><td style="text-align: left;">ELGA Mammogram Assessment</td></tr><tr style="vertical-align: top;"><th style="width: 20em; text-align: left;">Beschreibung</th><td style="text-align: left;" colspan="3">Definition der Werte für ein Mammogramm entsprechend DICOM Coding Scheme "BI" aus "Digital Imaging and Communications in Medicine (DICOM) Part 16: Content Mapping Resource"</td></tr><tr class="headinglabel"><th style="vertical-align: top; text-align: left;">Quell-Codesystem</th><td colspan="3" class="tabtab"><div style="width: 100%; margin: 4px 0px; background-color: #fff;">1.2.40.0.34.5.49 - <i>urn:oid:1.2.40.0.34.5.49</i></div></td></tr><tr><td colspan="4" class="tabtab"><table class="treetable" width="100%" border="0" cellspacing="0" cellpadding="5" id="transactionTable" style="background: transparent;"><tr style="background-color: #F6F3EE;"><th style="text-align: left;">Level/ Typ</th><th style="width: 100px; text-align: left;">Code</th><th style="text-align: left;">Anzeigename</th><th style="width: 200px; text-align: left;">Codesystem</th></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">II.AC.a</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">0 - Need additional imaging evaluation</div></td><td style="vertical-align: top;">1.2.40.0.34.5.49</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">II.AC.b.1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">1 – Negative</div></td><td style="vertical-align: top;">1.2.40.0.34.5.49</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">II.AC.b.2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">2 – Benign Finding</div></td><td style="vertical-align: top;">1.2.40.0.34.5.49</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">II.AC.b.3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">3 - Probably Benign Finding – short interval followup</div></td><td style="vertical-align: top;">1.2.40.0.34.5.49</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">II.AC.b.4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">4 - Suspicious abnormality, biopsy should be considered</div></td><td style="vertical-align: top;">1.2.40.0.34.5.49</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">MA.II.A.5.4A</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">4A – Low suspicion</div></td><td style="vertical-align: top;">1.2.40.0.34.5.49</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">MA.II.A.5.4B</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">4B – Intermediate suspicion</div></td><td style="vertical-align: top;">1.2.40.0.34.5.49</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">MA.II.A.5.4C</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">4C – Moderate suspicion</div></td><td style="vertical-align: top;">1.2.40.0.34.5.49</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">II.AC.b.5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">5 - Highly suggestive of malignancy, take appropriate action</div></td><td style="vertical-align: top;">1.2.40.0.34.5.49</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">MA.II.A.5.6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">6 - Known biopsy proven malignancy</div></td><td style="vertical-align: top;">1.2.40.0.34.5.49</td></tr><tr><td colspan="4"><hr /></td></tr></table></td></tr><tr class="desclabel"><td colspan="4">Legende: Typ L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors werden im @nullFlavor Attribut statt in @code angegeben. NullFlavor OTH (other) schlägt Text in originalText vor.</td></tr></table>
+
<table xmlns="http://www.w3.org/1999/xhtml" width="100%" border="0" cellspacing="3" cellpadding="2" class="artdecor " style="background: transparent;"><tr class="desclabel"><td colspan="4">Diese Terminologie ist eine Momentaufnahme vom . Terminologien können sich im Laufe der Zeit weiterentwickeln. Wenn eine neuere (dynamische) Versionen dieser Terminologie benötigt wird, bitte von der Quelle abrufen.</td></tr><tr style="vertical-align: top;"><th style="width: 20em; text-align: left;">Id</th><td style="text-align: left;">1.2.40.0.34.10.55</td><th style="width: 20em; text-align: left;">Gültigkeit</th><td style="text-align: left;">2015‑03‑31</td></tr><tr style="vertical-align: top;"><th style="width: 20em; text-align: left;">Status</th><td style="text-align: left;">[[File:Kgreen.png|14px]] Definitiv</td><th style="width: 20em; text-align: left;">Versions-Label</th><td style="text-align: left;"></td></tr><tr style="vertical-align: top;"><th style="width: 20em; text-align: left;">Name</th><td style="text-align: left;">ELGA_MammogramAssessment</td><th style="width: 20em; text-align: left;">Bezeichnung</th><td style="text-align: left;">ELGA Mammogram Assessment</td></tr><tr style="vertical-align: top;"><th style="width: 20em; text-align: left;">Beschreibung</th><td style="text-align: left;" colspan="3">Definition der Werte für ein Mammogramm entsprechend DICOM Coding Scheme "BI" aus "Digital Imaging and Communications in Medicine (DICOM) Part 16: Content Mapping Resource"</td></tr><tr class="headinglabel"><th style="vertical-align: top; text-align: left;">Quell-Codesystem</th><td colspan="3" class="tabtab"><div style="width: 100%; margin: 4px 0px; background-color: #fff;">1.2.40.0.34.5.49 - FHIR: <i>urn:oid:1.2.40.0.34.5.49</i></div></td></tr><tr><td colspan="4" class="tabtab"><table width="100%" border="0" cellspacing="0" cellpadding="5" id="transactionTable" class="artdecor treetable" style="background: transparent;"><tr style="background-color: #F6F3EE;"><th style="text-align: left;">Level/ Typ</th><th style="width: 100px; text-align: left;">Code</th><th style="text-align: left;">Bezeichnung</th><th style="width: 200px; text-align: left;">Codesystem</th></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">II.AC.a</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">0 - Need additional imaging evaluation</div></td><td style="vertical-align: top;">1.2.40.0.34.5.49</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">II.AC.b.1</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">1 – Negative</div></td><td style="vertical-align: top;">1.2.40.0.34.5.49</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">II.AC.b.2</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">2 – Benign Finding</div></td><td style="vertical-align: top;">1.2.40.0.34.5.49</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">II.AC.b.3</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">3 - Probably Benign Finding – short interval followup</div></td><td style="vertical-align: top;">1.2.40.0.34.5.49</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">II.AC.b.4</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">4 - Suspicious abnormality, biopsy should be considered</div></td><td style="vertical-align: top;">1.2.40.0.34.5.49</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">MA.II.A.5.4A</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">4A – Low suspicion</div></td><td style="vertical-align: top;">1.2.40.0.34.5.49</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">MA.II.A.5.4B</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">4B – Intermediate suspicion</div></td><td style="vertical-align: top;">1.2.40.0.34.5.49</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">MA.II.A.5.4C</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">4C – Moderate suspicion</div></td><td style="vertical-align: top;">1.2.40.0.34.5.49</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">II.AC.b.5</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">5 - Highly suggestive of malignancy, take appropriate action</div></td><td style="vertical-align: top;">1.2.40.0.34.5.49</td></tr><tr><td style="vertical-align: top;">0‑L</td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">MA.II.A.5.6</div></td><td style="vertical-align: top;" class="columnName"><div style="padding-left: 0px;">6 - Known biopsy proven malignancy</div></td><td style="vertical-align: top;">1.2.40.0.34.5.49</td></tr><tr><td colspan="4"><hr /></td></tr></table></td></tr><tr class="desclabel"><td colspan="4">Legende: Typ L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavor OTH (other) schlägt Text in originalText vor. HL7 V3: NullFlavors werden im @nullFlavor Attribut statt in @code angegeben.</td></tr></table>
<!--cf414f5a21c6ebc98c65738f6efbf08a417c42a3-->
+
<!--61998452fe6bab1bdc7b59d91cc27f7eea2cbb0f-->

Aktuelle Version vom 15. November 2022, 00:17 Uhr

Diese Terminologie ist eine Momentaufnahme vom . Terminologien können sich im Laufe der Zeit weiterentwickeln. Wenn eine neuere (dynamische) Versionen dieser Terminologie benötigt wird, bitte von der Quelle abrufen.
Id1.2.40.0.34.10.55Gültigkeit2015‑03‑31
StatusKgreen.png DefinitivVersions-Label
NameELGA_MammogramAssessmentBezeichnungELGA Mammogram Assessment
BeschreibungDefinition der Werte für ein Mammogramm entsprechend DICOM Coding Scheme "BI" aus "Digital Imaging and Communications in Medicine (DICOM) Part 16: Content Mapping Resource"
Quell-Codesystem
1.2.40.0.34.5.49 - FHIR: urn:oid:1.2.40.0.34.5.49
Level/ TypCodeBezeichnungCodesystem
0‑L
II.AC.a
0 - Need additional imaging evaluation
1.2.40.0.34.5.49
0‑L
II.AC.b.1
1 – Negative
1.2.40.0.34.5.49
0‑L
II.AC.b.2
2 – Benign Finding
1.2.40.0.34.5.49
0‑L
II.AC.b.3
3 - Probably Benign Finding – short interval followup
1.2.40.0.34.5.49
0‑L
II.AC.b.4
4 - Suspicious abnormality, biopsy should be considered
1.2.40.0.34.5.49
0‑L
MA.II.A.5.4A
4A – Low suspicion
1.2.40.0.34.5.49
0‑L
MA.II.A.5.4B
4B – Intermediate suspicion
1.2.40.0.34.5.49
0‑L
MA.II.A.5.4C
4C – Moderate suspicion
1.2.40.0.34.5.49
0‑L
II.AC.b.5
5 - Highly suggestive of malignancy, take appropriate action
1.2.40.0.34.5.49
0‑L
MA.II.A.5.6
6 - Known biopsy proven malignancy
1.2.40.0.34.5.49

Legende: Typ L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavor OTH (other) schlägt Text in originalText vor. HL7 V3: NullFlavors werden im @nullFlavor Attribut statt in @code angegeben.